Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
KR |
|
Beneteau SA
PAR:BEN
|
FR |
Intrinsic Value
The intrinsic value of Kyung Nam Pharm Co Ltd (053950) under the Base Case is 1 096.54 KRW per share. Compared with the current market price of 1 766 KRW, the stock appears Overvalued by 38% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Kyung Nam Pharm Does
Kyungnam Pharm Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Uiryeong-Gun, Gyeongsangnam-Do. The company went IPO on 2001-11-06. The firm's product portfolio consists of vitamin products, placenta products, health food products and general pharmaceuticals. The firm provides vitamin products under the brand name LEMONA. The company supplies health food products such as lactobacillus products through convenient stores and marts.
- Headquarters
- Korea KR
- IPO date
- Nov 6, 2001
Revenue & Expenses Breakdown
Kyung Nam Pharm Co Ltd
Earnings Waterfall
Kyung Nam Pharm Co Ltd
The intrinsic value for Kyung Nam Pharm Co Ltd (053950) under the Base Case is 1 096.54 KRW.
Compared with the current market price of 1 766 KRW, the stock appears Overvalued by 38% .